Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP267885.RAcK7eXVA5IX7zuNuFh9fA3Mkda4jTUB4teIkMCKt8lKE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP267885.RAcK7eXVA5IX7zuNuFh9fA3Mkda4jTUB4teIkMCKt8lKE130_assertion type Assertion NP267885.RAcK7eXVA5IX7zuNuFh9fA3Mkda4jTUB4teIkMCKt8lKE130_head.
- NP267885.RAcK7eXVA5IX7zuNuFh9fA3Mkda4jTUB4teIkMCKt8lKE130_assertion wasGeneratedBy ECO_0000203 NP267885.RAcK7eXVA5IX7zuNuFh9fA3Mkda4jTUB4teIkMCKt8lKE130_provenance.
- NP267885.RAcK7eXVA5IX7zuNuFh9fA3Mkda4jTUB4teIkMCKt8lKE130_assertion wasDerivedFrom befree-20140225 NP267885.RAcK7eXVA5IX7zuNuFh9fA3Mkda4jTUB4teIkMCKt8lKE130_provenance.
- NP267885.RAcK7eXVA5IX7zuNuFh9fA3Mkda4jTUB4teIkMCKt8lKE130_assertion SIO_000772 20966544 NP267885.RAcK7eXVA5IX7zuNuFh9fA3Mkda4jTUB4teIkMCKt8lKE130_provenance.
- NP267885.RAcK7eXVA5IX7zuNuFh9fA3Mkda4jTUB4teIkMCKt8lKE130_assertion evidence source_evidence_literature NP267885.RAcK7eXVA5IX7zuNuFh9fA3Mkda4jTUB4teIkMCKt8lKE130_provenance.
- NP267885.RAcK7eXVA5IX7zuNuFh9fA3Mkda4jTUB4teIkMCKt8lKE130_assertion description "[We determined whether JAK2 undergoes the V617F activating mutation during clinical progression of human prostate cancer using a highly sensitive assay (amplification refractory mutation system) and a unique material of fresh specimens from organ-confined or castration-resistant prostate cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP267885.RAcK7eXVA5IX7zuNuFh9fA3Mkda4jTUB4teIkMCKt8lKE130_provenance.